Guide To Beating Hypoglycemia

Most Effective Hypoglycemia Treatment

Get Instant Access

Thiazolidinediones, when used as monotherapy, are not associated with hypoglycemia, as they do not increase insulin secretion. Thiazolidinediones decrease the secretory demands and the strain on the b-cell caused by chronic insulin resistance and may preserve pancreatic b-cell function. Individuals using rosiglitazone or pioglitazone in combination with secretagogues or insulin therapy are at risk for hypoglycemic events.

In addition to their contribution as insulin sensitizers for glycemic control, the thiazolidinediones potentially have beneficial effects on endothelial function, atherogenesis, fibrinolysis, and ovarian steroidogenesis. Thiazolidinediones exhibit potent anti-inflammatory properties, and in recent clinical studies have been shown to retard the progression and reverse carotid intimal medial thickening, and decrease coronary intimal hyperplasia, in individuals with and without coronary stents. It remains unclear if these anti-inflammatory properties are unique to thiazolidinediones specifically or result from improvements in insulin resistance.

Was this article helpful?

0 0
Delicious Diabetic Recipes

Delicious Diabetic Recipes

This brilliant guide will teach you how to cook all those delicious recipes for people who have diabetes.

Get My Free Ebook

Post a comment